IRIS - Res&Arch Institutional Research Information System - Research & Archive

DE SOCIO, GIUSEPPE VITTORIO LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.878
NA - Nord America 2.129
EU - Europa 1.546
SA - Sud America 1.027
AF - Africa 96
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 7.680
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.025
SG - Singapore 1.168
BR - Brasile 763
VN - Vietnam 462
CN - Cina 381
HK - Hong Kong 267
RU - Federazione Russa 250
IT - Italia 245
KR - Corea 196
IE - Irlanda 194
FR - Francia 181
DE - Germania 154
SE - Svezia 141
UA - Ucraina 124
AR - Argentina 90
GB - Regno Unito 76
IN - India 69
FI - Finlandia 66
TR - Turchia 56
EC - Ecuador 49
MX - Messico 46
BD - Bangladesh 43
ID - Indonesia 42
IQ - Iraq 38
CA - Canada 36
CO - Colombia 36
VE - Venezuela 29
AT - Austria 26
ZA - Sudafrica 25
PK - Pakistan 18
PL - Polonia 17
SA - Arabia Saudita 17
UZ - Uzbekistan 17
JP - Giappone 16
MA - Marocco 16
NL - Olanda 16
CL - Cile 15
PY - Paraguay 15
PE - Perù 13
PH - Filippine 13
ES - Italia 12
EG - Egitto 11
LB - Libano 11
JO - Giordania 10
BO - Bolivia 9
AE - Emirati Arabi Uniti 8
CR - Costa Rica 8
KE - Kenya 7
MY - Malesia 7
DZ - Algeria 6
UY - Uruguay 6
AL - Albania 5
BE - Belgio 5
GR - Grecia 5
LT - Lituania 5
PS - Palestinian Territory 5
RO - Romania 5
AZ - Azerbaigian 4
ET - Etiopia 4
GA - Gabon 4
IL - Israele 4
OM - Oman 4
TH - Thailandia 4
TN - Tunisia 4
BH - Bahrain 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
KW - Kuwait 3
KZ - Kazakistan 3
SD - Sudan 3
SN - Senegal 3
AU - Australia 2
BZ - Belize 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
HU - Ungheria 2
JM - Giamaica 2
ML - Mali 2
MU - Mauritius 2
NO - Norvegia 2
NP - Nepal 2
PT - Portogallo 2
RS - Serbia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BJ - Benin 1
BT - Bhutan 1
BY - Bielorussia 1
GE - Georgia 1
GN - Guinea 1
GY - Guiana 1
HN - Honduras 1
HT - Haiti 1
IR - Iran 1
KG - Kirghizistan 1
LV - Lettonia 1
LY - Libia 1
Totale 7.668
Salva come PNG Salva come JPEG
Città #
Singapore 778
Hong Kong 265
San Jose 207
Seoul 195
Chandler 193
Dublin 191
Ashburn 157
Ho Chi Minh City 153
Lauterbourg 127
Columbus 99
Piscataway 93
Moscow 91
San Mateo 86
Hanoi 81
Santa Clara 76
São Paulo 73
Beijing 71
Dong Ket 67
Boardman 62
Jacksonville 58
Perugia 58
New York 57
Munich 55
Altamura 54
Los Angeles 46
Medford 45
Princeton 45
Lawrence 38
Wilmington 38
Ann Arbor 33
Council Bluffs 33
Rio de Janeiro 33
Hefei 30
The Dalles 30
Helsinki 26
Des Moines 24
Mexico City 22
Nuremberg 21
Falls Church 20
Frankfurt am Main 20
Haiphong 20
Dallas 19
Andover 17
Guayaquil 17
Chennai 16
Curitiba 16
Orem 16
Tokyo 16
Baghdad 15
Denver 15
Turku 15
Amsterdam 14
Florence 14
Houston 13
Montreal 13
Quito 13
Vienna 13
Warsaw 13
Caracas 12
Milan 12
Padova 12
Porto Alegre 12
Rome 12
Tashkent 12
Ankara 11
Belo Horizonte 11
Guangzhou 11
Guarulhos 11
Medellín 11
Ninh Bình 11
Poplar 11
Riyadh 11
Boston 10
Brasília 10
Brooklyn 10
Falkenstein 10
Izmir 10
London 10
Salvador 10
Toronto 10
Woodbridge 10
Bologna 9
Campinas 9
Da Nang 9
Dhaka 9
Johannesburg 9
Manaus 9
Mersin 9
Norwalk 9
Stockholm 9
Amman 8
Atlanta 8
Biên Hòa 8
Hải Dương 8
Istanbul 8
Jakarta 8
Redmond 8
Thái Bình 8
Bogotá 7
Buenos Aires 7
Totale 4.535
Salva come PNG Salva come JPEG
Nome #
Accelerate Pheno™ system in sepsis by Gram-negative pathogens: four months of hospital experience 160
Aortic stiffness in untreated adult patients with human immunodeficiency virus infection. 145
Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection 140
Accelerate Pheno™ blood culture detection system: a literature review 131
Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection. 125
Acute cytomegalovirus meningomyelitis in an immunocompetent patient. 124
Achromobacter denitrificans renal abscess. 122
Measurement and prediction of antimicrobial resistance in bloodstream infections by ESKAPE pathogens and Escherichia coli 112
Partial achievement of the 90-90-90 UNAIDS target in a cohort of HIV infected patients from Central Italy 110
Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection. 108
Accuracy and impact on patient management of new tools for diagnosis of sepsis: Experience with the t2 magnetic resonance bacteria panel 102
Hepatitis C virus genotypes in the liver and serum of patients with chronic hepatitis C 100
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia A Randomized Clinical Trial 100
Smoking Habits in Human Immunodeficiency Virus-Infected People from Italy: A Cross-Sectional Analysis of the STOPSHIV Cohort 99
National Early Warning Score 2 (NEWS2) better predicts critical Coronavirus Disease 2019 (COVID-19) illness than COVID-GRAM, a multi-centre study 96
Pre and Post-Monoclonal Infusion Neutralizing Activity in a Subgroup of Patients Treated in the Presence of two SARS-CoV-2 Dominant Variant of Concern (VOCs) and an Ongoing Vaccination. Overall Clinical Efficacy of Two Monoclonal Antibodies Association in Umbria 95
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: A cross-sectional study 94
Delivery in asymptomatic Italian woman with SARS-CoV-2 infection 93
[Loa loa filariasis in Italy: review of the literature with a clinical report] 91
Semiquantitative PCR in the diagnosis of HIV infection: correlation to clinical stage and serological status. 90
Evaluation of IVD 3.0 Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Mycobacterium tuberculosis and nontuberculous mycobacteria and its use in routine diagnostics. 90
Prevalence of smoking and nicotine dependence in HIV patients, the project STOPS HIV from Italy 85
Early treatment with bamlanivimab alone does not prevent COVID-19 hospitalization and its post-acute sequelae. A real experience in Umbria, Italy 85
Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients 83
XVI Convegno Nazionale AIDS e SINDROMI CORRELATE 82
Is it feasible to impact on smoking habits in HIV-Infected patients? Mission impossible from the STOPSHIV Project cohort 82
Smoking habits in HIV-infected people compared with the general population in Italy: A cross-sectional study 82
Infezioni da Cytomegalovirus nel paziente immunodepresso. 81
Decreasing cardiovascular risk in HIV infection between 2005 and 2011. 81
Negative influence of HIV infection on day-night blood pressure variability. 78
Lingual tubercolosis: a rare disease in western countries 78
An unusual case of epigastric and back pain: expanding descending thoracic aneurysm resulting from tertiary syphilis diagnosed with positron emission tomography. 77
Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH) 75
Laboratory automation reduces time to report of positive blood cultures and improves management of patients with bloodstream infection 74
Le infezioni da Cytomegalovirus ed il loro trattamento nel paziente immunodepresso (AIDS e TMO). 73
HIV infection and antiretroviral treatment: a "two-hit" model for arterial stiffness? 69
Improving the etiological diagnosis of osteoarticular infections with the commercial multiplex real-time polymerase chain reaction SeptiFast® 69
Dolutegravir/Lamivudine versus Tenofovir Alafenamide/Emtricitabine/Bictegravir as a Switch Strategy in a Real-Life Cohort of Virogically Suppressed People Living with HIV 64
Impact of smoking habits on cardiovascular and neoplastic events and all-cause death in people living with HIVfrom the STOPSHIV cohort 61
Fusobacterium nucleatum endocarditis mimicking polymyalgia rheumatica 61
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 60
Observed versus predicted cardiovascular events and all-cause death in HIV infection: A longitudinal cohort study 59
Laboratory automation, informatics, and artificial intelligence: current and future perspectives in clinical microbiology 57
AmBisome administration for Candida albicans shunt infections 57
Bictegravir and Dolutegravir have no impact on glucose levels 12 months after initiation 55
Retroperitoneal abscess: an uncommon localization of tubercular infection. 55
Symmetric ambulatory arterial stiffness index and 24-h pulse pressure in HIV infection: results of a nationwide cross-sectional study 54
Thrombocytopenia in HIV infected patients: prevalence and clinical spectrum 53
Liver enzyme variation after switching to emtricitabine/tenofovir alafenamide/bictegravir is associated with glucose increase in a real-life cohort 52
Antiretroviral therapy and adverse skeletal effects 52
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade 52
Real-life monocentric Biktarvy cohort from Perugia 51
Giant Infective Endocarditis of Native Aortic Valve with Secondary Mitral Kissing Vegetation 51
Prevalence, awareness, treatment, and control rate of hypertension in HIV-infected patients: the HIV-HY study. 50
Lack of HIV seroconversion in a patient treated immediately with antiretroviral therapy at acute infection and virus relapse 48
[Renal toxicity in HIV-infected patients receiving HAART including tenofovir] 48
Ageing with HIV: a multidisciplinary review 47
Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 46
[Low incidence of streptococcal pharyngitis in young adults] 46
HIV Infection - Screening, Diagnosis, and Treatment 46
Knowledge of STIs and HIV among people with and without HIV: where are we now? 46
Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study 45
Effectiveness, safety and tolerability of dolutegravir/lamivudine versus tenofovir alafenamide/emtricitabine/bictegravir in a real-life cohort of HIV-1 virologically suppressed treatment experienced people living with HIV 45
Hypophosphatemic Osteomalacia Associated with Tenofovir: a Multidisciplinary Approach is Required 44
A study of SARS-CoV-2 epidemiology in Italy: from early days to secondary effects after social distancing 44
Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry 44
96 Week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experience 44
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: the HIV and Hypertension Study 43
Use of a molecular syndromic panel for the etiological diagnosis of ventilator-associated bacterial pneumonia: impact on clinical outcomes and antibiotic use from a multicenter, prospective study 42
Schizophrenia, drug therapy, and monitoring 41
Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study 41
Screening for Latent Tuberculosis Infection in People Living with HIV: TUBHIVIT Project, a Multicenter Italian Study 40
The use of nucleoside reverse transcriptase inhibitors sparing regimens in treatment-experienced HIV-1 infected patients 40
Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients. A survey among Italian HIV physicians 40
A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks' observational data 40
Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting 40
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years 39
Factors Associated With Weight Gain in People Treated With Dolutegravir 39
Safety and efficacy of switching people with HIV to dual treatment with 3TC/DTG and RPV/DTG in real life: results from the SCOLTA cohort 39
Waist circumference and body mass index in HIV infection 39
Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project 38
Knowledge of Sexually Transmitted Infections and HIV among People Living with HIV: Should We Be Concerned? 38
Adefovir induced hypophosphatemic osteomalacia 38
With or without TAF? What is the difference? Data from a real-life setting 38
People with HIV pioneers of injectable cabotegravir and rilpivirine long acting in Italy: who are they? 37
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry 37
UV-C Irradiation Effectiveness on Mpox-Virus-Contaminated Surfaces 37
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project 37
Il fumo di sigaretta, un fattore di rischio maggiore per la popolazione HIV-positiva: strategie di intervento 36
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA) 35
Role of Normalized T-Cell Subsets in Predicting Comorbidities in a Large Cohort of Geriatric HIV-Infected Patients 35
Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: the SALIR-E Study 35
Metabolic syndrome: a real threat for HIV-positive patients?: Results from the SIMONE study 35
Trajectories of CD4+/CD8+ T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study 35
Reversibility of Central Nervous System Adverse Events in Course of Art 35
Efficacy and Tollerability of INI-Based 2-Drug Regimen in Virosuppressed Persons Living with HIV: A Systematic Review and Meta-Analysis 35
Is metabolic syndrome associated to HIV infection per se? Results from the HERMES study 34
Real-life safety of Emtricitabine/Tenofovir Alafenamide/Bictegravir 34
Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study (vol 72, pg 2879, 2017) 34
Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian "GEPPO" Cohort 34
Totale 6.358
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.403
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.403
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021117 0 0 0 0 0 0 0 0 0 16 27 74
2021/2022362 9 58 10 25 18 15 7 91 13 13 47 56
2022/2023675 48 130 11 54 44 83 9 23 246 0 16 11
2023/2024267 11 32 14 5 4 1 69 3 23 11 50 44
2024/20251.311 9 66 24 28 75 47 54 55 213 277 199 264
2025/20264.776 308 385 449 1.174 422 231 614 316 493 384 0 0
Totale 7.989